Atovaquone and Proguanil Hydrochloride (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Atovaquone and Proguanil Hydrochloride drug offered from Mylan Pharmaceuticals Inc.. This Antimalarial [EPC],Antiprotozoal [EPC],Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | atovaquone and proguanil hydrochloride |
| SUBSTANCE NAME: | ATOVAQUONE; PROGUANIL HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antimalarial [EPC],Antiprotozoal [EPC],Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2014-05-28 |
| END MARKETING DATE: | 0000-00-00 |
Atovaquone and Proguanil Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Atovaquone and Proguanil Hydrochloride from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 62.5; 25(mg/1; mg/1) |
| START MARKETING DATE: | 2014-05-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-4160_e8bfc355-f102-4b15-8435-837c2afa6952 |
| PRODUCT NDC: | 0378-4160 |
| APPLICATION NUMBER: | ANDA202362 |
Other ATOVAQUONE; PROGUANIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
